Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study

le de Vries, Juna M, van der Beek, Nadine AME, Hop, Wim CJ, Karstens, Francois PJ, Wokke, John H, de Visser, Marianne, van Engelen, Baziel GM, Kuks, Jan BM, van der Kooi, Anneke J, Notermans, Nicolette C, Faber, Catharina G, Verschuuren, Jan JGM, Kruijshaar, Michelle E, Reuser, Arnold JJ, van Doorn, Pieter A, van der Ploeg, Ans T
Foilsithe 2012

Afamelanotide for Erythropoietic Protoporphyria

le Langendonk, Janneke G., Balwani, Manisha, Anderson, Karl E., Bonkovsky, Herbert L., Anstey, Alexander V., Bissell, D. Montgomery, Bloomer, Joseph, Edwards, Chris, Neumann, Norbert J., Parker, Charles, Phillips, John D., Lim, Henry W., Hamzavi, Iltefat, Deybach, Jean-Charles, Kauppinen, Raili, Rhodes, Lesley E., Frank, Jorge, Murphy, Gillian M., Karstens, Francois P.J., Sijbrands, Eric J.G., de Rooij, Felix W.M., Lebwohl, Mark, Naik, Hetanshi, Goding, Colin R., Wilson, J.H. Paul, Desnick, Robert J.
Foilsithe in N Engl J Med (2015)